Panel Presentation: Understanding iRAEs from Immune Checkpoint Inhibitors

preview_player
Показать описание

  1. RheumNow
  2. Rheumatoid
  3. arthritis
  4. Rheumatology
  5. Lupus
  6. Vasculitis
Рекомендации по теме
Panel Presentation: Understanding 0:05:24

Panel Presentation: Understanding iRAEs from Immune Checkpoint Inhibitors

Monitoring, managing, and 0:21:59

Monitoring, managing, and mitigating immune-related adverse events

Expert Discusses Studying 0:00:36

Expert Discusses Studying irAEs in Patients With ICC

Panel Discussion: iRAE 0:17:44

Panel Discussion: iRAE Sessions and Studies

Webinar: The evolution 0:54:33

Webinar: The evolution of Response Evaluation Criteria in Cancer Immunotherapy

iRAEs, Treatments for 0:05:58

iRAEs, Treatments for Checkpoint Inhibitor Inflammatory Arthritis and PMR

Project Data Sphere 0:32:40

Project Data Sphere - irAE symposium panel discussion - 03/30/2021

irAEs with single-agent 0:02:33

irAEs with single-agent PD-1 vs PD-L1 inhibitors

SITC clinical practice 0:01:35

SITC clinical practice guidelines on immune checkpoint inhibitor-related adverse events

RheumNow Live Preview 0:02:02

RheumNow Live Preview with Dr. Len Calabrese (iRAEs)

Understanding and Working 0:38:09

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC

irAEs: Drs. Cassie 0:10:39

irAEs: Drs. Cassie Calabrese and David Liew

Managing Adverse Events 0:42:23

Managing Adverse Events Associated with Immuno-oncologic Agents | Dr. Igor Puzanov

Neurological adverse events 0:03:54

Neurological adverse events associated with immune checkpoint inhibitors

2 Panel 1:30:10

2 Panel Discussion

Updating Our Cardio-Oncology 1:37:52

Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Management of Cardiac irAEs

Live from the 0:58:30

Live from the Lab with Sonia Sharma, Ph.D., presenting Building Better Cancer Immunotherapy

AACR 2023 Poster 0:07:01

AACR 2023 Poster Presentation

An International Panel 0:16:19

An International Panel Weighs in on RA Studies from Day 1 at ACR

WCLC 2019: David 0:01:01

WCLC 2019: David Heigener discussing anti-angiogenic vs immune checkpoint inhibitor

Checkpoint Inhibitors in 0:04:19

Checkpoint Inhibitors in Second and Third-line

Experts Davies, Gubens, 1:37:27

Experts Davies, Gubens, & Waxman discuss #NSCLC - https://bit.ly/41AxLLC

“Rheumatologic Consequences of 1:02:47

“Rheumatologic Consequences of Immune Checkpoint Inhibitors”, Annual Kessler Lecture, Dr. Ami Shah...

Here's what happened 0:00:34

Here's what happened after Chinese President Xi Jinping's aide arrived late for the BRICS ...